A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group Study S0202

BACKGROUND: Patients with gallbladder cancer or cholangiocarcinoma usually present with advanced disease and limited treatment options. Based on the common embryologic origin of the exocrine pancreas and gallbladder, coupled with data demonstrating effectiveness of gemcitabine in pancreatic carcinom...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Iqbal, Syma, Rankin, Cathryn, Lenz, Heinz-Josef, Gold, Philip J., Ahmad, Syed A., El-Khoueiry, Anthony B., Messino, Michael J., Holcombe, Randall F., Blanke, Charles D.
Формат: Artigo
Язык:Inglês
Опубликовано: 2011
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3519425/
https://ncbi.nlm.nih.gov/pubmed/21556747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-011-1657-1
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы